Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Dohi, Kenji ^a   Ohtaki, Hirokazu ^a   Nakamachi, Tomoya ^a   Yofu, Sachiko ^a   Satoh, Kazue ^a   Miyamoto, Kazuyuki ^a   Song, Dandan ^a   Tsunawaki, Shohko ^b   Shioda, Seiji ^a   Aruga, Tohru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; NITRIC OXIDE; OXYGEN; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; CYBB PROTEIN, MOUSE; CYTOCHROME B; INTERLEUKIN 10; MEMBRANE PROTEIN; P22(PHOX) PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL ACTIVATION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME KINETICS; ENZYME REGULATION; ENZYME SYNTHESIS; GENE DELETION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MICROGLIA; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRAUMATIC BRAIN INJURY; UPREGULATION; WESTERN BLOTTING; WILD TYPE; ANIMAL; BRAIN; BRAIN INJURY; C57BL MOUSE; CELL LINE; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN; BRAIN INJURIES; CELL LINE; CYTOCHROME B GROUP; GENE DELETION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICROGLIA; NADPH OXIDASE; PHENOTYPE; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 77954877602     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-41     Document Type: Article

References (43)

1. Dohi K, Satoh K, Nakamachi T, Yofu S, Hiratsuka K, Nakamura S, Ohtaki H, Yoshikawa T, Shioda S, Aruga T. Does edaravone (MCI- 186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury?. Antioxid Redox Signal 2007, 9:281-287. 10.1089/ars.2007.9.281, 17115943.
2. Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma 2000, 17:871-890. 10.1089/neu.2000.17.871, 11063054.
3. Pratico D, Reiss P, Tang LX, Sung S, Rokach J, McIntosh TK. Local and systemic increase in lipid peroxidation after moderate experimental traumatic brain injury. J Neurochem 2002, 80:894-898. 10.1046/j.0022-3042.2002.00777.x, 11948253.
4. Tyurin VA, Tyurina YY, Borisenko GG, Sokolova TV, Ritov VB, Quinn PJ, Rose M, Kochanek P, Graham SH, Kagan VE. Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J Neurochem 2000, 75:2178-2189. 10.1046/j.1471-4159.2000.0752178.x, 11032908.
5. Deng-Bryant Y, Singh IN, Carrico KM, Hall ED. Neuroprotective effects of tempol, a catalytic scavenger of peroxynitrite-derived free radicals, in a mouse traumatic brain injury model. J Cereb Blood Flow Metab 2008, 28:1114-1126. 10.1038/jcbfm.2008.10, 18319733.
6. Lewen A, Skoglosa Y, Clausen F, Marklund N, Chan PH, Lindholm D, Hillered L. Paradoxical increase in neuronal DNA fragmentation after neuroprotective free radical scavenger treatment in experimental traumatic brain injury. J Cereb Blood Flow Metab 2001, 21:344-350. 10.1097/00004647-200104000-00003, 11323520.
7. Floyd RA, Carney JM. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 1992, 32(Suppl):S22-27. 10.1002/ana.410320706, 1510377.
8. Abramov AY, Duchen MR. The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides. Philos Trans R Soc Lond B Biol Sci 2005, 360:2309-2314. 10.1098/rstb.2005.1766, 1569597, 16321801.
9. Infanger DW, Sharma RV, Davisson RL. NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal 2006, 8:1583-1596. 10.1089/ars.2006.8.1583, 16987013.
10. Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 2004, 95:1019-1026. 10.1161/01.RES.0000148637.85595.c5, 15499027.
11. Bedard K, Lardy B, Krause KH. NOX family NADPH oxidases: not just in mammals. Biochimie 2007, 89:1107-1112. 10.1016/j.biochi.2007.01.012, 17400358.
12. Huang J, Canadien V, Lam GY, Steinberg BE, Dinauer MC, Magalhaes MA, Glogauer M, Grinstein S, Brumell JH. Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci USA 2009,
13. Huang J, Canadien V, Lam GY, Steinberg BE, Dinauer MC, Magalhaes MA, Glogauer M, Grinstein S, Brumell JH. Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci USA 2009,
14. Zekry D, Epperson TK, Krause KH. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia?. IUBMB Life 2003, 55:307-313. 10.1080/1521654031000153049, 12938732.
15. Dinauer MC, Deck MB, Unanue ER. Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes. J Immunol 1997, 158:5581-5583.
16. Morikawa K, Dohi K, Yofu S, Mihara Y, Nakamachi T, Ohtaki H, Shioda S, Aruga T. Expression and Localization of Pituitary Adenylate Cyclase-Activating Polypeptide-Specific Receptor (PAC1R)..After Traumatic Brain Injury in Mice. Open Crit Care Med J 2008, 1:33-38.
17. Henn A, Lund S, Hedtjarn M, Schrattenholz A, Porzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex 2009, 26:83-94.
18. Yoshida LS, Saruta F, Yoshikawa K, Tatsuzawa O, Tsunawaki S. Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase. J Biol Chem 1998, 273:27879-27886. 10.1074/jbc.273.43.27879, 9774399.
19. Bindokas VP, Jordan J, Lee CC, Miller RJ. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 1996, 16:1324-1336.
20. Gordon S. rnative activation of macrophages. Nat Rev Immunol 2003, 3:23-35. 10.1038/nri978, 12511873.
21. Corraliza I, Campo M, Soler G, Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994, 174:231-235. 10.1016/0022-1759(94)90027-2, 8083527.
22. Serrano F, Kolluri NS, Wientjes FB, Card JP, Klann E. NADPH oxidase immunoreactivity in the mouse brain. Brain Res 2003, 988:193-198. 10.1016/S0006-8993(03)03364-X, 14519542.
23. Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, Fujimoto S. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 2000, 273:5-9. 10.1006/bbrc.2000.2897, 10873554.
24. Jackman KA, Miller AA, De Silva TM, Crack PJ, Drummond GR, Sobey CG. Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br J Pharmacol 2009, 156:680-688. 10.1111/j.1476-5381.2008.00073.x, 2697707, 19175604.
25. Tang J, Liu J, Zhou C, Ostanin D, Grisham MB, Neil Granger D, Zhang JH. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage. J Neurochem 2005, 94:1342-1350. 10.1111/j.1471-4159.2005.03292.x, 16011743.
26. Anantharam V, Kaul S, Song C, Kanthasamy A, Kanthasamy AG. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology 2007, 28:988-997. 10.1016/j.neuro.2007.08.008, 2140261, 17904225.
27. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000, 87:26-32.
28. Hilburger EW, Conte EJ, McGee DW, Tammariello SP. Localization of NADPH oxidase subunits in neonatal sympathetic neurons. Neurosci Lett 2005, 377:16-19. 10.1016/j.neulet.2004.11.066, 15722179.
29. Miller AA, Dusting GJ, Roulston CL, Sobey CG. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke. Brain Res 2006, 1111:111-116. 10.1016/j.brainres.2006.06.082, 16879806.
30. Green SP, Cairns B, Rae J, Errett-Baroncini C, Hongo JA, Erickson RW, Curnutte JT. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J Cereb Blood Flow Metab 2001, 21:374-384. 10.1097/00004647-200104000-00006, 11323523.
31. Qin B, Cartier L, Dubois-Dauphin M, Li B, Serrander L, Krause KH. A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiol Aging 2006, 27:1577-1587. 10.1016/j.neurobiolaging.2005.09.036, 16260066.
32. Fabian RH, DeWitt DS, Kent TA. In vivo detection of superoxide anion production by the brain using a cytochrome c electrode. J Cereb Blood Flow Metab 1995, 15:242-247.
33. Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall ED. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood Flow Metab 2006, 26:1407-1418. 10.1038/sj.jcbfm.9600297, 16538231.
34. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69. 10.1038/nrn2038, 17180163.
35. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387-1394. 10.1038/nn1997, 17965659.
36. Streit WJ. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci 2006, 29:506-510. 10.1016/j.tins.2006.07.001, 16859761.
37. Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, Prockop DJ. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 2008, 105:14638-14643. 10.1073/pnas.0803670105, 2567180, 18794523.
38. Huh PW, Belayev L, Zhao W, Clemens JA, Panetta JA, Busto R, Ginsberg MD. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats. Eur J Pharmacol 2000, 389:79-88. 10.1016/S0014-2999(99)00768-2, 10686299.
39. Lambeth JD, Krause KH, Clark RA. NOX enzymes as novel targets for drug development. Semin Immunopathol 2008, 30:339-363. 10.1007/s00281-008-0123-6, 18509646.
40. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, Brandes RP. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 2007, 38:3000-3006. 10.1161/STROKEAHA.107.489765, 17916764.
41. Tang J, Liu J, Zhou C, Ostanin D, Grisham MB, Granger DN, Zhang JH. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage. J Neurochem 2005, 94:1342-1350. 10.1111/j.1471-4159.2005.03292.x, 16011743.
42. Lo W, Bravo T, Jadhav V, Titova E, Zhang JH, Tang J. NADPH oxidase inhibition improves neurological outcomes in surgically-induced brain injury. Neurosci Lett 2007, 414:228-232. 10.1016/j.neulet.2006.12.055, 1857328, 17317004.
43. Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH. Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can J Neuro sci 2007, 34:356-361.